China Digest: Hrain Biotech raises $29m Series B+; Qiming leads new funding in Weier

Hrain Biotechnology has pocketed 200 million yuan ($29 million) in a Series B+ round, while Weier Technology has raised “tens of millions of US dollars” in a Series B round led by Qiming Venture Partners.